Further studies revealed that dual VEGF–Ang2 blockade leads to the upregulation of PD-L1 on ECs and tumor cells, which may be a possible mechanism of resistance to dual VEGF–Ang2 blockade (11, 81). The gene discussed is VEGFA; the disease is neoplasm.